Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Assura appoints Steven Noble to newly-created role of CIO

(Sharecast News) - Specialist healthcare property investor and developer Assura said on Monday that it has appointed Steven Noble to the newly-created role of chief investment officer to support the business' short and long-term growth strategy. Noble will join the company with immediate effect and will be responsible for implementing Assura's investment strategy across all healthcare markets, including delivery of capital recycling initiatives.

He was most recently CIO at Atrato Group, the investment adviser to Atrato Onsite Energy (ROOF) and Supermarket Income REIT (SUPR), where he negotiated and executed over £2bn of property transactions and played an important role in taking SUPR from IPO to the FTSE 250, Assura said.

Prior roles include nine years at Lloyds in origination and risk management with a focus on commercial real estate and KPMG where he qualified as a chartered accountant.

Assura chief executive Jonathan Murphy said: "Steven's appointment to the newly created role of chief investment officer is an important strategic step for Assura to support our ambitious growth plans. The UK healthcare crisis continues to worsen with an immense need for improved access to healthcare services across the country.

"These factors are driving demand for infrastructure across an increasingly diverse range of healthcare markets, to which Assura is best placed to respond owning to our market position, sector expertise and capabilities and our strong corporate culture.

"Steven's skills and expertise will complement those already within the Executive Committee to deliver against this demand and our long-term growth strategy."

Share this article

Related Sharecast Articles

Berenberg lowers target price on Impax Asset Management
(Sharecast News) - Analysts at Berenberg lowered their target price on Impax Asset Management from 620.0p to 560.0p on Tuesday but noted that outflows had started to slow.
GSK's Arexvy provides protection over three RSV seasons, trial shows
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three seasons.
S&U revenue up, profitability a challenge in first half
(Sharecast News) - Motor and property finance specialist S&U reported a mixed first-half financial performance on Tuesday, after group revenue increased 9% year-on-year to £60.4m.
Loungers reports slight slowdown in LFL sales growth
(Sharecast News) - Cosy Club owner Loungers reported a slight slowdown in like-for-like sales growth on Tuesday and a jump in revenue.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.